Experimental Drugs for Panic Disorder: An Updated Systematic Review

Experimental Drugs for Panic Disorder: An Updated Systematic Review

Daniela Caldirola,1,2 Alessandra Alciati,1– 3 Francesco Cuniberti,1,2 Giampaolo Perna1,2 1Department of Biomedical Sciences, Humanitas University, Milan, 20090, Italy; 2Department of Clinical Neurosciences, Villa San Benedetto Menni Hospital, Hermanas Hospitalarias, Como, 22032, Italy; 3Hu...

Full description

Bibliographic Details
Main Authors:	Caldirola D, Alciati A, Cuniberti F, Perna G
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-04-01
Series:	Journal of Experimental Pharmacology
Subjects:	novel drug experimental therapy orexin d-cycloserine xenon gas
Online Access:	https://www.dovepress.com/experimental-drugs-for-panic-disorder-an-updated-systematic-review-peer-reviewed-fulltext-article-JEP

Similar Items

Xenon in the treatment of panic disorder: an open label study
by: Alexander Dobrovolsky, et al.
Published: (2017-06-01)

Cycloserine induced delirium during treatment of multi-drug resistant tuberculosis (MDR-TB)
by: Gayatri Saraf, et al.
Published: (2015-04-01)

Pharmacological-assisted Psychotherapy for Post Traumatic Stress Disorder: a systematic review and meta-analysis
by: Mathew D. Hoskins, et al.
Published: (2021-01-01)

Deterioration of Cycloserine in Drug Susceptibility Testing of Mycobacterium
by: Wang R, et al.
Published: (2022-01-01)

Minimum inhibitory concentration of cycloserine against Mycobacterium tuberculosis using the MGIT 960 system and a proposed critical concentration
by: Xiao Wu, et al.
Published: (2022-08-01)

A Review of the Actions of D-cycloserine, a Putative Nootropic Agent, at the NMDA Receptor Complex-Associated Glycine Binding Site
by: J.W Allen
Published: (2020-12-01)

Psychiatric disorders in patients with multidrug resistant tuberculosis (MDR-TB) in Sardjito Hospital, Yogyakarta, Indonesia
by: Irwan Supriyanto, et al.
Published: (2017-08-01)

Cycloserine induced mania
by: Ajay Kumar Bakhla, et al.
Published: (2013-01-01)

An Evaluation of the Effects of D-Cycloserine on Operant Learning and Response Recovery
by: Consuelo San Martín, et al.
Published: (2022-11-01)

Cycloserine Induced Psychosis, Insomnia and Suicidal Attempts in a Young Female Patient with Pre-Extensively Drug Resistant Tuberculosis
by: Priyanka Pravinbhai Hotha, et al.
Published: (2022-12-01)

Comparative Evaluation of the Efficacy and Tolerability of Chemotherapy in Patients with Drug-Resistant Pulmonary Tuberculosis Using Terizidone and Cycloserine in the Comprehensive Treatment
by: O.M. Raznatovska, et al.
Published: (2015-11-01)

Adverse drug reactions due to cycloserine on the central nervous system in the multidrug-resistant tuberculosis cases: a case series
by: Sankalp Yadav, et al.
Published: (2019-11-01)

Determination of <span style="font-variant: small-caps">d</span>-Cycloserine Impurities in Pharmaceutical Dosage Forms: Comparison of the International Pharmacopoeia HPLC–UV Method and the DOSY NMR Method
by: Damjan Makuc, et al.
Published: (2020-04-01)

Potential of D-cycloserine in the treatment of behavioral and neuroinflammatory disorders in Parkinson's disease and studies that need to be performed before clinical trials
by: Cornelius Rainer Pawlak, et al.
Published: (2012-08-01)

Case report on cycloserine serum levels after treatment with oral terizidone and oral cycloserine
by: Lauren Rose, et al.
Published: (2024-01-01)

A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in Mycobacterium tuberculosis
by: Wouter Deelder, et al.
Published: (2022-01-01)

The Co-Morbidity between Bipolar and Panic Disorder in Fibromyalgia Syndrome
by: Alessandra Alciati, et al.
Published: (2020-11-01)

Digging Deeper to Save the Old Anti-tuberculosis Target: D-Alanine–D-Alanine Ligase With a Novel Inhibitor, IMB-0283
by: Jianzhou Meng, et al.
Published: (2020-01-01)

The Efficacy of Augment of D-Cycloserine and Cognitive-behavioral Therapy on Adolescent with one Type of Anxiety Disorders: A Double-blind Randomized Controlled Trial
by: Soroor Arman, et al.
Published: (2017-01-01)

The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis
by: Lingyun Mao, et al.
Published: (2022-09-01)

Role of Glutamatergic Modulators in the Treatment of Obsessive Compulsive and Related Disorders
by: Fatma Gül Helvacı Çelik, et al.
Published: (2024-09-01)

Cycloserine-induced psychosis in patients with drug-resistant tuberculosis: a systematic review of case reports
by: Alonso Cotrina-Santome, et al.
Published: (2023-03-01)

Safety of parapulmonal application of xenon in the experiment
by: V. V. Khinovker, et al.
Published: (2022-09-01)

Assessment of the neuroprotective potential of d-cycloserine and l-serine in aluminum chloride-induced experimental models of Alzheimer’s disease: In vivo and in vitro studies
by: Özlem Özdemir Tozlu, et al.
Published: (2022-09-01)

Increase in mRNA Level of Orexin1 and 2 Receptors Following Induction of Experimental Autoimmune Encephalomyelitis in Mice
by: Iman Fatemi, et al.
Published: (2016-01-01)

Characterization of serine hydroxymethyltransferase GlyA as a potential source of D-alanine in Chlamydia pneumoniae
by: Stefania eDe Benedetti, et al.
Published: (2014-02-01)

Pharmacological modulation of the short-lasting effects of antagonistic direct current-stimulation over the human motor cortex
by: Leila eChaieb, et al.
Published: (2012-07-01)

Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis
by: Richard Court, et al.
Published: (2021-04-01)

Sikloserin ile ilişkili mani
by: Soner Çakmak, et al.
Published: (2016-12-01)

Investigation of the Effect of Cycloserine on Motor Function in a Rat Model of Parkinson’s disease
by: Reza Taherian, et al.
Published: (2017-10-01)

COVID-19 and panic disorder: clinical considerations for the most physical of mental disorders
by: Giampaolo Perna, et al.
Published: (2020-08-01)

Neuroenhancement of Exposure Therapy in Anxiety Disorders
by: Stefan G. Hofmann, et al.
Published: (2015-07-01)

Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation
by: Pascal Bonaventure, et al.
Published: (2017-06-01)

XENON1T excess: Some possible backgrounds
by: Biplob Bhattacherjee, et al.
Published: (2021-06-01)

Sleep-wake and arousal dysfunctions in post-traumatic stress disorder: Role of orexin systems
by: Gary B. Kaplan, et al.
Published: (2022-08-01)

High Incidence of Psychiatric Disorders Associated with Cycloserine Treatment of Multidrug-Resistant Tuberculosis Patients: A Cohort Study in Beijing, China
by: Pang Y, et al.
Published: (2022-07-01)

Noble gas and neuroprotection: From bench to bedside
by: Haiying Yin, et al.
Published: (2022-11-01)

Is panic disorder a disorder of physical fitness? A heuristic proposal [version 1; referees: 2 approved]
by: Giampaolo Perna, et al.
Published: (2018-03-01)

Association of schizophrenia onset age and white matter integrity with treatment effect of D-cycloserine: a randomized placebo-controlled double-blind crossover study
by: Kazuo Takiguchi, et al.
Published: (2017-07-01)

Prevalence of nontuberculous mycobacteria and high efficacy of D-cycloserine and its synergistic effect with clarithromycin against Mycobacterium fortuitum and Mycobacterium abscessus
by: Khosravi AD, et al.
Published: (2018-12-01)